Home > Boards > US OTC > Miscellaneous > Kannalife Inc. (KLFE)

Kannalife, Inc. (“Kannalife”), is a pharmaceutical and phyto-medical

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Papa Bear Member Profile
 
Followed By 1,161
Posts 60,819
Boards Moderated 6
Alias Born 07/30/10
160x600 placeholder
Papa Bear   Sunday, 01/20/19 08:17:49 PM
Re: None
Post # of 11 
Kannalife, Inc. (“Kannalife”), is a pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. Kannalife currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the Commercialization of U.S. Patent #6630507, “Cannabinoids as Antioxidants and Neuroprotectants” (the “‘507 Patent”). Further, Kannalife has developed its own patented molecules lead by KLS-13019 called by Sports Illustrated as a “super-CBD” and was recently awarded U.S. Patent #9611213, “Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy”.

Kannalife is currently conducting research and development at the Bucks County Pennsylvania Biotechnology Center in Doylestown, PA, for a target drug candidate to treat Hepatic Encephalopathy (“HE”), Chronic Traumatic Encephalopathy (“CTE”) and Chemotherapy Induced Peripheral Neuropathy (“CIPN”). HE and CTE are both oxidative stress related diseases that affects the cognitive and behavioral functions, and the wellness of the brain. CIPN is a neurodegenerative condition that afflicts patients undergoing chemotherapy with symptoms that include numbness, tingling, and pain.

Please checkout my new board! Name of the board is: "The OTC Casino!"

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141097769
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist